<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Home and office treatment of symptomatic hemorrhoids</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Home and office treatment of symptomatic hemorrhoids</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Home and office treatment of symptomatic hemorrhoids</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ronald Bleday, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth Breen, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin Weiser, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 25, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hemorrhoids are collections of submucosal, fibrovascular, arteriovenous sinusoids that are part of the normal anorectum [<a href="#rid1">1</a>]. In epidemiologic studies conducted in Korea, England, and Austria, between 14 and 39 percent of the population had hemorrhoids; however, many were without symptoms [<a href="#rid2">2-4</a>]. Hemorrhoids without any symptoms do not require treatment. </p><p>By contrast, an estimated 10 million people in the United States complained of hemorrhoids, corresponding to a prevalence of 4.4 percent [<a href="#rid5">5</a>]. The most common complaint associated with hemorrhoidal disease is painless rectal bleeding during defecation with or without tissue prolapse. Other typical symptoms include anal pruritus or pain and a lump at the anal verge due to thrombosis or strangulation [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/2541.html" rel="external">"Hemorrhoids: Clinical manifestations and diagnosis", section on 'Clinical manifestations'</a>.)</p><p>Those presenting for symptomatic hemorrhoids probably represent a group with relatively severe disease. Because a large variety of over-the-counter products are available and marketed for the treatment of hemorrhoids, patients often self-diagnose and self-treat before seeking medical attention. Incidentally, the quality of information about hemorrhoids on the internet is highly variable, and a significant proportion of websites assessed are poorly informed (40 percent in one study [<a href="#rid6">6</a>]).</p><p>Several options are available for the treatment of symptomatic hemorrhoids, and most patients with low-grade internal hemorrhoids will have relief with home-based conservative treatment or office-based procedures that are reviewed in this topic. Surgery is indicated for low-grade hemorrhoids that are refractory to home- or office-based treatments, high-grade hemorrhoids, and complicated hemorrhoids. Surgical treatment of hemorrhoids is reviewed separately. (See  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease"</a>.)</p><p class="headingAnchor" id="H128870939"><span class="h1">CLASSIFICATION OF HEMORRHOIDS</span><span class="headingEndMark"> — </span>Hemorrhoids are classified relative to their relationship to the dentate line  (<a class="graphic graphic_figure graphicRef80650" href="/d/graphic/80650.html" rel="external">figure 1</a>): </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Internal</strong> hemorrhoids are proximal to or above the dentate line. Tissues above the dentate line receive visceral innervation, which is less sensitive to pain and irritation. Thus, internal hemorrhoids are amenable to a variety of office-based procedures that can be carried out with minimal or no anesthesia. Internal hemorrhoids are further subclassified into four grades based on the degree of prolapse from the anal canal  (<a class="graphic graphic_figure graphicRef113938" href="/d/graphic/113938.html" rel="external">figure 2</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>External</strong> hemorrhoids are distal to or below the dentate line, where tissues are innervated somatically, and therefore are more sensitive to pain and irritation. As a result, symptomatic external hemorrhoids that are refractory to conservative management are generally treated surgically under anesthesia, with the exception of small, acutely thrombosed external hemorrhoids, which can sometimes be treated in the office.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mixed</strong> internal and external hemorrhoids straddle the dentate line and are generally treated in the same way as are external hemorrhoids. </p><p></p><p class="headingAnchor" id="H2908561537"><span class="h1">TREATMENT APPROACHES BY SYMPTOMS</span><span class="headingEndMark"> — </span>Patients generally complain of hemorrhoids for one of four symptoms:</p><p class="headingAnchor" id="H1124893909"><span class="h2">Irritation or pruritus</span><span class="headingEndMark"> — </span>Irritation or pruritus from internal or external hemorrhoids (no bleeding or thrombosis) can be treated with a variety of analgesic creams, <a class="drug drug_general" data-topicid="8535" href="/d/drug information/8535.html" rel="external">hydrocortisone</a> suppositories, and warm sitz baths  (<a class="graphic graphic_table graphicRef103146" href="/d/graphic/103146.html" rel="external">table 1</a>). These treatments, particularly hydrocortisone, should not be used for longer than one week, since side effects may occur, such as contact dermatitis with analgesic creams or mucosal atrophy with steroid creams [<a href="#rid7">7,8</a>]. If there is no improvement after one week, other nonsteroidal creams can be tried. (See <a class="local">'Medications for symptomatic relief'</a> below.)</p><p class="headingAnchor" id="H1181632595"><span class="h2">Bleeding hemorrhoids</span><span class="headingEndMark"> — </span>External hemorrhoids generally do not bleed, unless a patient has spontaneously evacuated a thrombosed hemorrhoid; it is usually self-limited. Treatment of bleeding hemorrhoids is initially conservative, such as with dietary modification or external creams (see <a class="local">'Conservative treatment for all patients'</a> below). Persistently bleeding internal hemorrhoids can be treated using office-based procedures (eg, rubber band ligation). For external hemorrhoids, the only alternative is surgery since external hemorrhoids are not amenable to banding. (See <a class="local">'Office-based procedures for symptomatic hemorrhoids'</a> below.)</p><p class="headingAnchor" id="H3841871586"><span class="h2">Thrombosed hemorrhoids</span><span class="headingEndMark"> — </span>Thrombosis is usually associated with pain. Organization and resorption of clot occurs within several days following thrombosis of internal or external hemorrhoids, lessening the degree of pain. Conservative treatment of thrombosed hemorrhoids is usually sufficient. Exceptions include those with severe pain and thrombosed external hemorrhoids and the rare case of concomitant thrombosis of external and internal hemorrhoids (sometimes seen after childbirth). It is important to appreciate that thrombosis of grade III and IV internal hemorrhoids usually persists after the conservative therapies outlined above and may require definitive treatment. (See  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease", section on 'Thrombosed external hemorrhoids'</a>.)</p><p class="headingAnchor" id="H531315529"><span class="h2">Prolapsed internal hemorrhoids</span><span class="headingEndMark"> — </span>Internal hemorrhoids are graded from I to IV  (<a class="graphic graphic_figure graphicRef113938" href="/d/graphic/113938.html" rel="external">figure 2</a>). As the grade becomes worse, there is a greater benefit to office-based procedures or surgery. For grade III hemorrhoids, one can first try rubber band ligation, which is often successful after one or two applications (see <a class="local">'Office-based procedures for symptomatic hemorrhoids'</a> below). If the rubber band ligation is not effective, then surgery is recommended. For grade IV hemorrhoids, surgery is the best treatment. (See  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease", section on 'Indications'</a>.)</p><p class="headingAnchor" id="H813383083"><span class="h1">CONSERVATIVE TREATMENT FOR ALL PATIENTS</span><span class="headingEndMark"> — </span>The initial treatment approach to most patients with new-onset symptomatic hemorrhoids is conservative, consisting of dietary/lifestyle modification and topical or oral medications to relieve symptoms  (<a class="graphic graphic_table graphicRef103146" href="/d/graphic/103146.html" rel="external">table 1</a>). Conservative treatment is successful for most patients and can be continued for as long as the patient wishes. </p><p class="headingAnchor" id="H3103367213"><span class="h2">Dietary and lifestyle modification</span><span class="headingEndMark"> — </span>There is strong evidence from multiple randomized trials that increased fiber intake improves symptoms of hemorrhoid bleeding and mild prolapse [<a href="#rid9">9</a>]. The other recommendations for dietary and lifestyle modifications are based on common sense rather than data. </p><p class="bulletIndent1"><span class="glyph">●</span>Patients should ingest 20 to 30 g of insoluble fiber per day  (<a class="graphic graphic_table graphicRef82094" href="/d/graphic/82094.html" rel="external">table 2</a>) and drink plenty of water (1.5 to 2 liters per day). Both are necessary to produce regular, soft stools, which reduce straining at defecation. It could take six weeks to fully realize the beneficial effect of fiber [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1">Many commercially available fiber supplements are available to reduce constipation. Many contain either <a class="drug drug_general" data-topicid="9834" href="/d/drug information/9834.html" rel="external">psyllium</a> or <a class="drug drug_general" data-topicid="10153" href="/d/drug information/10153.html" rel="external">methylcellulose</a>. Neither has been shown to have a particular advantage over the other in treating hemorrhoidal disease. For patients who are unwilling to take fiber supplements, a detailed listing of the fiber content of various foods can be helpful  (<a class="graphic graphic_table graphicRef82094" href="/d/graphic/82094.html" rel="external">table 2</a>). Because fiber has other salutary effects, is safe to use, and may help to prevent recurrence, we recommend augmentation of fiber in the diet indefinitely.</p><p></p><p class="bulletIndent1">Adding fiber to the diet is beneficial for patients with bleeding [<a href="#rid9">9,11</a>]. A 2005 Cochrane meta-analysis of seven trials found that fiber supplementation decreased hemorrhoid bleeding (risk reduction [RR] 0.50, 95% CI 0.28-0.68) and overall symptoms (eg, prolapse, pain, or itch; RR 0.47, 95% CI 0.32-0.68) [<a href="#rid9">9</a>]. </p><p></p><p class="bulletIndent1">In an illustrative study, supplementation with <a class="drug drug_general" data-topicid="9834" href="/d/drug information/9834.html" rel="external">psyllium</a> for six weeks was associated with improvement in bleeding compared with untreated controls [<a href="#rid10">10</a>]. In a later trial, 50 patients with bleeding internal hemorrhoids were randomly assigned to receive either a commercially available fiber preparation (<em>Plantago ovata</em>) or placebo [<a href="#rid12">12</a>]. Endoscopy was performed before and after treatment. After 15 days of treatment, those who had received fiber supplementation had significantly fewer bleeding episodes and a reduction in the number of hemorrhoids seen on endoscopy. </p><p></p><p class="bulletIndent1">The benefit of fiber for irritation, pruritus, or prolapse is less well established than for bleeding [<a href="#rid9">9</a>]. Fiber supplementation may relieve pruritus related to fecal soilage since the bulking effect of fiber may reduce leakage of liquid stool. In one study, fiber supplementation had no effect on hemorrhoidal prolapse [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should refrain from straining or lingering (eg, reading) on the toilet. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should have regular physical exercise.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If possible, patients should avoid medications that can cause constipation  (<a class="graphic graphic_table graphicRef62307" href="/d/graphic/62307.html" rel="external">table 3</a>) or diarrhea  (<a class="graphic graphic_table graphicRef71449" href="/d/graphic/71449.html" rel="external">table 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should also limit their intake of fatty foods and alcohol, which can exacerbate constipation [<a href="#rid13">13</a>]. Although a popular myth, eating spicy food (eg, red hot chili peppers) had no effect on hemorrhoid symptoms such as irritation and pruritus in a controlled study [<a href="#rid14">14</a>]. </p><p></p><p class="headingAnchor" id="H662041969"><span class="h2">Medications for symptomatic relief</span><span class="headingEndMark"> — </span>Numerous medications, many over the counter, are available to treat hemorrhoids. Commonly used medications for hemorrhoids include oral or local analgesics to treat pain, topical agents to reduce local swelling or treat contact dermatitis, therapies to reduce sphincter spasm, and venoactive agents (phlebotonics) to increase venous tone of hemorrhoidal tissues. Each of these may be effective for treating one or more of the symptoms of hemorrhoidal disease (ie, irritation, pruritus, bleeding, thrombosis, pain)  (<a class="graphic graphic_table graphicRef103146" href="/d/graphic/103146.html" rel="external">table 1</a>).</p><p>However, data on long-term efficacy or side effects are lacking, with a few exceptions. There is high-quality evidence that phlebotonics (eg, flavonoid, hydroxyethylrutoside, calcium dobesilate) can improve hemorrhoid symptoms such as itch and bleeding. The use of phlebotonics for hemorrhoids is common in Europe and Asia but not North America. Other medical therapies for symptomatic hemorrhoid disease are poorly studied in the medical literature. The choice of these medications is informed more by marketing and patient perception than by actual evidence. </p><p class="headingAnchor" id="H2727784815"><span class="h3">Topical analgesics and steroids</span><span class="headingEndMark"> — </span>Topical ointments containing anesthetics, steroids, emollients, and antiseptics are often self-prescribed by the patients for quick symptomatic relief. However, there is a lack of strong scientific evidence that supports the use of topical ointments.</p><p>Topical analgesics, such as mixed <a class="drug drug_general" data-topicid="10121" href="/d/drug information/10121.html" rel="external">lidocaine-hydrocortisone</a>, are effective for relieving acute pain associated with hemorrhoids. However, topical ointments should not be used for longer than one week, to avoid adverse effects such as contact dermatitis [<a href="#rid7">7,8</a>]. </p><p>Topical steroids, such as <a class="drug drug_general" data-topicid="8535" href="/d/drug information/8535.html" rel="external">hydrocortisone</a> cream or suppository, may shrink the hemorrhoids and relieve the associated pruritus but have not been well evaluated for effectiveness in treating thrombosed hemorrhoids. If they are used, some experts suggest applying cream rather than using suppositories. Steroid cream should be applied twice a day for no more than seven days. Long-term use should be avoided because of potential thinning of perianal and anal mucosa and increasing risk of injury. If symptoms are persistent, an alternative nonsteroidal ointment should be used. (See  <a class="medical medical_review" href="/d/html/5565.html" rel="external">"Topical corticosteroids: Use and adverse effects"</a>.)</p><p class="headingAnchor" id="H3036067013"><span class="h3">Venoactive agents</span><span class="headingEndMark"> — </span>Phlebotonics are primarily used in Europe and Asia to treat acutely inflamed and bleeding hemorrhoids. Phlebotonics have not been approved by the US Food and Drug Administration for the indication of hemorrhoids.</p><p>Phlebotonics are a heterogenous class of drugs consisting of plant extracts (ie, flavonoids such as hydroxyethylrutoside) and synthetic compounds (eg, calcium dobesilate) [<a href="#rid15">15</a>]. Because phlebotonics improve venous tone, microvascular permeability, lymphatic activity, and microcirculatory nutritive flow [<a href="#rid16">16</a>], they may reduce bleeding associated with hemorrhoids. Some studies have found that hydroxyethylrutoside reduces acute and recurrent hemorrhoidal attacks, including those in pregnant women [<a href="#rid17">17-22</a>]. In one study, phlebotonics were useful in bridging patients with advanced hemorrhoid disease to surgery [<a href="#rid23">23</a>]. However, many of the studies had important methodological limitations [<a href="#rid24">24</a>]. </p><p>A 2012 Cochrane review of 24 randomized trials showed a significant beneficial effect of phlebotonics for outcomes such as pruritus (odds ratio [OR] 0.23, 95% CI 0.07-0.79), bleeding (OR 0.12, 95% CI 0.04-0.37), and overall symptomatic improvement (OR 15.99, 95% CI 5.97-42.84) but less for pain (OR 0.11, 95% CI 0.01-1.11) [<a href="#rid25">25</a>]. In addition, phlebotonics also alleviated post-hemorrhoidectomy symptoms. </p><p class="headingAnchor" id="H2877411617"><span class="h3">Antispasmodic agents</span><span class="headingEndMark"> — </span>Several types of agents (nitric oxide donors) can be useful for reducing anal sphincter spasm. A small series suggested that topical 0.5% <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a> ointment may provide temporary analgesia by reducing internal anal sphincter spasm [<a href="#rid26">26</a>]. This dose may be associated with side effects such as headache. A lower dose of nitroglycerin has been used in patients with anal fissures [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/d/html/83135.html" rel="external">"Anal fissure: Medical management", section on 'Topical vasodilators'</a>.)</p><p>In one report, <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a> (glyceryl trinitrate) ointment (0.2%, Rectogesic) was effective in controlling bleeding, pain, itch, irritation, and difficulty in defecation [<a href="#rid28">28</a>]. <a class="drug drug_general" data-topicid="8580" href="/d/drug information/8580.html" rel="external">Isosorbide dinitrate</a> ointment was also used to treat symptomatic hemorrhoids with good results in a small study [<a href="#rid29">29</a>]. A small controlled trial suggested a benefit of topical <a class="drug drug_general" data-topicid="9700" href="/d/drug information/9700.html" rel="external">nifedipine</a> [<a href="#rid30">30</a>]. Another small trial found that a single intrasphincteric injection of botulinum toxin significantly reduced pain intensity within 24 hours [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H210705289"><span class="h3">Sitz baths</span><span class="headingEndMark"> — </span>Sitz baths are an intuitive topical treatment for acute flare-ups of hemorrhoids to reduce inflammation and edema and relax the sphincter muscles. Patients with significant hemorrhoid disease tend to have elevated sphincter tone. Manometric studies have confirmed that application of moist heat to the perianal area can lower the internal sphincter and anal canal pressures [<a href="#rid32">32</a>]. Sitz baths can relieve irritation and pruritus as well as spasm of the anal sphincter muscles. They should be used with warm, rather than cold, water two to three times per day [<a href="#rid33">33</a>]. A commercially available portable bowl allows for use at the workplace. </p><p class="headingAnchor" id="H962841373"><span class="h1">REASONS TO REFER TO A SPECIALIST</span><span class="headingEndMark"> — </span>Hemorrhoids are a common problem that is generally diagnosed and treated by general practitioners. Most patients with low-grade (I or II) internal hemorrhoids respond favorably to conservative treatment. Such patients do not require any further treatment. Reasons to refer patients to a specialist include refractory or complicated hemorrhoids for possible intervention and rectal bleeding for possible colonoscopy.</p><p class="headingAnchor" id="H167754597"><span class="h2">Refer for procedure</span><span class="headingEndMark"> — </span>Patients should be referred to a colorectal or general surgeon for:</p><p class="bulletIndent1"><span class="glyph">●</span>Symptomatic low-grade (I or II) internal hemorrhoids refractory to six to eight weeks of medical treatment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptomatic high-grade (III or IV) internal hemorrhoids.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thrombosed hemorrhoids, with the exception of subacute (older than three days) thrombosed external hemorrhoids, which can be managed expectantly with resolution of symptoms expected in 7 to 10 days.</p><p></p><p>The specific indications and technical aspects of office-based procedures and surgical hemorrhoidectomy are discussed in detail elsewhere. (See <a class="local">'Office-based procedures for symptomatic hemorrhoids'</a> below and  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease"</a>.)</p><p class="headingAnchor" id="H261726100"><span class="h2">Refer for colonoscopy</span><span class="headingEndMark"> — </span>For patients who present with rectal bleeding, colonoscopy is generally recommended for those ≥40 years to exclude more serious underlying disease (eg, malignancy). For patients younger than 40 who have no risk factors for colonic disease and no evidence of other anorectal abnormalities, hemorrhoid treatment can be administered without further endoscopy or imaging studies. Persistent bleeding after successful local treatment of hemorrhoids should prompt referral for colonoscopy in those patients [<a href="#rid1">1</a>].</p><p>Patients with hemorrhoids and one of the following conditions should be referred for colonoscopy regardless of age [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Anemia</p><p class="bulletIndent1"><span class="glyph">●</span>Bleeding that is atypical of hemorrhoids</p><p class="bulletIndent1"><span class="glyph">●</span>A concomitant change in bowel patterns</p><p class="bulletIndent1"><span class="glyph">●</span>A personal history of colorectal polyps</p><p class="bulletIndent1"><span class="glyph">●</span>A family history of inflammatory bowel disease or colorectal cancer in a first-degree relative</p><p class="bulletIndent1"><span class="glyph">●</span>Other suspected pathologic pelvic changes that could contribute to the patient's symptoms</p><p></p><p class="headingAnchor" id="H438681270"><span class="h1">OFFICE-BASED PROCEDURES FOR SYMPTOMATIC HEMORRHOIDS</span><span class="headingEndMark"> — </span>Office-based procedures are typically offered to patients who have symptomatic internal hemorrhoids that are refractory to conservative medical treatments. The common objective of these therapies is to cause sloughing of excess hemorrhoidal tissue; healing and scarring then fixes the residual tissue to the underlying anorectal muscular ring. In a 2005 Cochrane review of three randomized trials, surgical hemorrhoidectomy was associated with more pain (relative risk 1.94, 95% CI 1.62-2.33) and complications (relative risk 6.32, 95% CI 1.15-34.89) than rubber band ligation [<a href="#rid34">34</a>]. </p><p>For patients with symptomatic grade I, II, or III internal hemorrhoids refractory to conservative treatment, we recommend an office-based procedure, rather than surgical hemorrhoidectomy, as the initial intervention  (<a class="graphic graphic_figure graphicRef113938" href="/d/graphic/113938.html" rel="external">figure 2</a>). Although some surgeons feel that grade III internal hemorrhoids, especially those with multiple pedicles, should be treated surgically, we recommend attempting rubber band ligation at least once. The recovery after rubber band ligation is vastly easier than after hemorrhoidectomy. If rubber band ligation fails to control symptoms adequately, surgery can then be offered.</p><p>Patients with internal hemorrhoids of any grade <strong>and</strong> additional anorectal problems, external hemorrhoids, or mixed internal/external hemorrhoids should proceed directly to surgery as those conditions are not amenable to office-based treatments.</p><p class="headingAnchor" id="H104856039"><span class="h2">Choice of office-based technique</span><span class="headingEndMark"> — </span>Commonly performed office-based procedures include rubber band ligation, sclerotherapy, infrared coagulation of internal hemorrhoids, and excision of thrombosed external hemorrhoids [<a href="#rid35">35-37</a>]. The choice first depends on local availability. When local expertise is available for more than one procedure, we suggest the following [<a href="#rid1">1,11,38</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>For healthy patients with grade I, II, or III internal hemorrhoids, we recommend rubber band ligation rather than another procedure. Compared with sclerotherapy or infrared coagulation, rubber band ligation is more effective and requires fewer treatment sessions [<a href="#rid39">39,40</a>]. (See <a class="local">'Rubber band ligation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients who are on anticoagulant or antiplatelet drugs, are immunocompromised, or have portal hypertension, we suggest sclerotherapy rather than another procedure. In such patients, rubber band ligation is contraindicated due to the high risk of delayed bleeding, and sclerotherapy is better studied than infrared coagulation in the literature for this group of patients [<a href="#rid2">2</a>]. (See <a class="local">'Sclerotherapy'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acutely thrombosed external hemorrhoids can be treated by office-based excision if the patient presents within the first three days of symptoms. The symptoms usually begin to subside after three days and typically dissipate in 7 to 10 days. Extensive or bleeding thrombosed external hemorrhoids may require surgical excision in the operating room. (See  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease", section on 'Thrombosed external hemorrhoids'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Grade IV internal hemorrhoids require definitive surgical treatment. Office-based procedures are ineffective and should not be attempted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should be informed before the procedure that office-based procedures do not address any external component (eg, skin tag) of the hemorrhoid. </p><p></p><p class="headingAnchor" id="H438682430"><span class="h2">Techniques</span></p><p class="headingAnchor" id="H438685862"><span class="h3">Rubber band ligation</span><span class="headingEndMark"> — </span>Rubber band ligation is the most commonly used technique for the treatment of symptomatic bleeding internal hemorrhoids. This technique is effective, inexpensive, and easy to perform and only rarely causes serious complications. </p><p>Patients with grade II or III internal hemorrhoids are the best candidates for rubber band ligation. External tags and external hemorrhoids are <strong>not</strong> to be treated with this technique, as it would cause excruciating pain. Banding procedures are typically contraindicated in patients with coagulopathies and those on anticoagulation (eg, <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a>, <a class="drug drug_general" data-topicid="85642" href="/d/drug information/85642.html" rel="external">apixaban</a> [Eliquis], <a class="drug drug_general" data-topicid="8926" href="/d/drug information/8926.html" rel="external">dabigatran</a> [Pradaxa], <a class="drug drug_general" data-topicid="9498" href="/d/drug information/9498.html" rel="external">rivaroxaban</a> [Xarelto]) or antiplatelet (eg, <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a> [Plavix]) medications, and patients with cirrhosis and portal hypertension, because of the risk of significant delayed hemorrhage [<a href="#rid41">41</a>]. In the authors' experience, patients on <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> therapy can safely undergo rubber band ligation, with a low risk of bleeding. Banding is relatively contraindicated in immunocompromised patients (eg, chemotherapy administration, HIV/AIDS) because of risks of infection and sepsis [<a href="#rid42">42</a>]. (See <a class="local">'Choice of office-based technique'</a> above and <a class="local">'Immunocompromised patients'</a> below.)</p><p>When performed properly, this procedure does not require any anesthesia (local or intravenous). Usually, only one hemorrhoidal column should be treated at a time to minimize excessive tissue necrosis. However, if the patient tolerates the procedure with only minimal discomfort, then several hemorrhoids can be banded during the same session. As many as three bands in a single column may be safely performed [<a href="#rid43">43</a>]. If multiple sessions are needed, then repeat banding procedures can be performed in three- to four-week intervals to allow any swelling and ulcerations to subside. Many patients complain of anal or rectal "tightness" after the procedure. </p><p>Patients are placed in the semi-inverted jackknife or left lateral position. The procedure is performed through the anoscope, and small rubber band rings are placed onto the internal hemorrhoids traditionally using a forceps, but other methods have been developed  (<a class="graphic graphic_figure graphicRef63288" href="/d/graphic/63288.html" rel="external">figure 3</a> and <a class="graphic graphic_picture graphicRef89835" href="/d/graphic/89835.html" rel="external">picture 1</a>). When a forceps ligator is used to apply the bands, an assistant is required to stabilize the anoscope. Once the involved hemorrhoid is identified through an anoscope, the rubber ring ligating drum with two rubber rings is placed into the anal canal. The largest internal hemorrhoid should be treated first. The internal hemorrhoid is grasped with forceps, and the excess tissue is pulled toward the tip or drum of the handheld ligator gun apparatus while the trigger causes the release of the rubber band. The rubber rings are then advanced down to the neck of the hemorrhoid. The key technical point is to ensure the bands are placed at least 5 mm above the dentate line to avoid placement onto somatically innervated tissue. Severe pain will result from misapplication of the band below the dentate line or from associated spasm. Thus, prior to rubber band release, the patient should be questioned about the presence of pain, which may indicate the need to select a point more proximal in the anal canal. If a patient experiences intense or excruciating pain as the rubber band is placed, then the band should be removed immediately by cutting the rubber band. </p><p>Other application techniques have been described. Each uses the same principles as the traditional forceps approach described above.</p><p class="bulletIndent1"><span class="glyph">●</span>Endoscopic suction ligator – An alternative technique involves suction of the symptomatic hemorrhoid into the ligating drum, which is attached to an endoscope [<a href="#rid44">44-46</a>]. The ring is deployed through a trigger passed through the biopsy channel of the endoscope. This approach may allow for adequate ligation with fewer treatment sessions [<a href="#rid47">47</a>]. A single-handed nonendoscopic ligating device has also been used successfully and is less expensive than the endoscopic device [<a href="#rid48">48</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Wall suction ligator – Another technique uses a vacuum suction band ligator [<a href="#rid49">49</a>]. The application of the rubber band using wall suction can be performed in fewer sessions compared with the standard forceps technique (1.2 versus 2 sessions). The principles are the same, but the rubber band ligator is attached to wall suction. The operator places the drum with the rubber band against the hemorrhoid. Suction pulls the hemorrhoid into the drum, and the rubber band is deployed. The technical advantage is that the operator can hold the ligator and apply the band with one hand and hold the anoscope with the other unassisted. </p><p></p><p>Successful ligation results in thrombosis of the hemorrhoid and the development of localized submucosal scarring. The banded hemorrhoidal tissues immediately become ischemic and then necrotic in the next three to five days, forming an ulcerated tissue bed. Complete healing occurs several weeks later. </p><p>One of the largest series to describe long-term outcomes of rubber band ligation included 805 patients who underwent 2114 ligations (median of two ligations in each patient) [<a href="#rid50">50</a>]. Excluding 104 patients who were lost to follow-up, treatment was considered successful in 71 percent (80 percent when considering patients who underwent repeated treatment after initial failure). Success rates were similar for all degrees of hemorrhoids. A higher failure rate was observed in patients who required placement of four or more bands. </p><p>In a meta-analysis of 12 trials, bleeding stopped after rubber band ligation in up to 90 percent of patients; 78 to 84 percent of those with grade III (prolapsing) hemorrhoids reported symptomatic improvement, and only 50 percent of patients with grade IV hemorrhoids had improvement. The most common complications are bleeding and pain (8 to 80 percent) [<a href="#rid51">51</a>]. However, the success rate often decreases with longer follow-up (eg, 40 to 50 percent at one year [<a href="#rid52">52</a>]). </p><p>In a meta-analysis of 18 trials, rubber band ligation was more effective than injection sclerotherapy or infrared coagulation for the treatment of grade I, II, and III hemorrhoids, requiring fewer treatment sessions [<a href="#rid39">39,40</a>]. The risk of complications and pain tended to be greater for rubber band ligation compared with other techniques. Compared with surgery, rubber band ligation had more recurrent symptoms but was associated with fewer complications and pain. </p><p>Following rubber band ligation, the most frequent complication is pain, which occurs in approximately 8 percent [<a href="#rid43">43,50,53-55</a>]. Other complications include [<a href="#rid56">56</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Delayed hemorrhage – Delayed hemorrhage can occur when the rubber band dislodges, typically two to four days after application or with ulceration and mucosal sloughing, which can occur five to seven days after the procedure. Bleeding can be significant in patients with coagulation abnormalities.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhoidal thrombosis – Hemorrhoids distal to the treated hemorrhoid can thrombose, leading to pain or a palpable mass. (See <a class="local">'Thrombosed hemorrhoids'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Localized infection – Localized infection or abscess can occur at the site of band ligation. Persistent pain, fever, or foul-smelling rectal drainage may signal the onset of infection. Surgical drainage may be required. (See  <a class="medical medical_review" href="/d/html/1378.html" rel="external">"Perianal and perirectal abscess"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sepsis – Fulminant sepsis after hemorrhoid ligation is rare but has been reported [<a href="#rid53">53,54</a>]. (See <a class="local">'Postprocedure care and follow-up'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urinary retention.</p><p></p><p class="headingAnchor" id="H438682759"><span class="h3">Sclerotherapy</span><span class="headingEndMark"> — </span>Injectable sclerosant solutions can also be used to treat symptomatic internal hemorrhoids. The most common solution used is phenol (5%) in vegetable oil, although other sclerosants such as <a class="drug drug_general" data-topicid="9907" href="/d/drug information/9907.html" rel="external">polidocanol</a> foam [<a href="#rid57">57</a>], <a class="drug drug_general" data-topicid="9666" href="/d/drug information/9666.html" rel="external">sodium morrhuate</a>, <a class="drug drug_general" data-topicid="9847" href="/d/drug information/9847.html" rel="external">quinine</a>, urea hydrochloride, <a class="drug drug_general" data-topicid="10330" href="/d/drug information/10330.html" rel="external">sodium tetradecyl sulfate</a> (Sotradecol), and hypertonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> have all been used. The sclerosant causes an intense inflammatory reaction, destroying redundant submucosal tissue associated with hemorrhoidal prolapse. </p><p>As with rubber band ligation, sclerotherapy does not require anesthesia (local or intravenous). Patients are placed in the semi-inverted jackknife or left lateral position, and the procedure is performed through the anoscope. The internal hemorrhoids targeted for treatment are located and injected with 1 to 3 cc of the sclerosant material into the submucosa plane using a long intravenous 21-gauge needle or a spinal needle. A wheal should be raised with the solution. If the injection is too superficial, the area will become tense and blanched, and the injection should stop immediately to minimize risk of mucosal necrosis.</p><p>This approach can be used to treat grade I and II bleeding internal hemorrhoids with reported success rates of 75 to 89 percent [<a href="#rid58">58,59</a>], which has more recurrences than rubber band ligation [<a href="#rid40">40</a>]. In a meta-analysis of five trials, sclerotherapy resolved 90 to 100 percent of grade II hemorrhoids; 36 to 49 percent of patients reported postprocedural pain. Bleeding is rare after sclerotherapy [<a href="#rid51">51</a>].</p><p>Thus, sclerotherapy is especially beneficial to patients with an elevated bleeding risk (eg, those on anticoagulant or antiplatelet drugs and those with portal hypertension) due to a lack of eschar formation and patients who are immunocompromised due to a lower risk of anorectal sepsis compared with rubber band ligation or hemorrhoidectomy [<a href="#rid60">60</a>]. (See <a class="local">'Choice of office-based technique'</a> above.)</p><p>Complications of sclerotherapy are also uncommon, with the most frequent being minor discomfort or bleeding with the injection. Rectourethral fistulas, rectal perforations, and necrosing fasciitis are rare complications but can occur with misplaced injections into nonhemorrhoidal tissues or with systemic injections into the vasculature [<a href="#rid61">61-63</a>]. </p><p class="headingAnchor" id="H438682858"><span class="h3">Infrared coagulation</span><span class="headingEndMark"> — </span>Infrared coagulation involves the direct application of infrared light waves to the hemorrhoidal tissues. Patients with grade I or II bleeding internal hemorrhoids are candidates for this procedure.</p><p>Infrared coagulation is sometimes erroneously referred to as laser therapy. Infrared light waves are converted into heat, which results in protein necrosis within the hemorrhoid. This is seen as a white, blanching effect to the mucosa approximately 3 mm wide by 3 mm deep. Over a period of one to two weeks, the white, discolored mucosa changes into a dark scab and eventually leads to a puckered or ablated area, causing retraction of the redundant hemorrhoid mucosa.</p><p>The patient is positioned in the semi-inverted jackknife or left lateral position, and anoscopy is performed. The tip of the infrared coagulation applicator or probe is applied to the base of the internal hemorrhoid for two seconds, with three to five applications per hemorrhoid. </p><p>In a meta-analysis of four trials, 78, 51 and 22 percent of patients with grade I, II and III hemorrhoids reported improvement after infrared coagulation therapy [<a href="#rid51">51</a>]. Postoperative pain and bleeding occurred in 15 to 100 percent and 15 to 44 percent of patients, respectively. The recurrence rate was 13 percent at three months.</p><p>Compared with rubber band ligation, infrared coagulation is associated with more recurrences but fewer complications and causes less discomfort immediately after the procedure [<a href="#rid36">36</a>]. </p><p class="headingAnchor" id="H438685371"><span class="h3">Others</span><span class="headingEndMark"> — </span>Other techniques involve the application of monopolar cautery (electrotherapy), bipolar diathermy (Bicap, HET bipolar system), laser photocoagulation, or cryosurgery to cause coagulation and necrosis, which leads to fibrosis in the submucosal layer. They are generally effective for grade I to II internal hemorrhoids, and each has its advocates [<a href="#rid64">64-66</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Electrotherapy uses a probe to deliver an electric current to the base of the hemorrhoid above the dentate line to cause the hemorrhoid to shrink. It has been used to treat grade I to III internal hemorrhoids. A low-amplitude direct electric current setting (between 8 and 16 mA) can be used in an outpatient setting but often requires repeat procedures; the use of higher amplitudes (up to 30 mA) requires anesthesia [<a href="#rid67">67</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The HET bipolar system uses bipolar energy to treat symptomatic grade I and II internal hemorrhoids refractory to medical therapy [<a href="#rid68">68</a>]. Limited data have shown it to be safe, effective, and painless [<a href="#rid69">69</a>], and it may be an alternative to rubber band ligation for large internal hemorrhoids and those close to the dentate line. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhoidectomy using the neodymium-doped yttrium aluminium garnet (Nd:YAG) or carbon dioxide laser has been described [<a href="#rid70">70-72</a>]. However, these approaches do not appear to offer a significant advantage to other approaches, and the required equipment is expensive. Furthermore, serious complications have been described [<a href="#rid73">73</a>]. (See  <a class="medical medical_review" href="/d/html/2883.html" rel="external">"Basic principles of medical lasers"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cryosurgery is the application of special probes cooled with liquid nitrogen, which causes freezing, necrosis, and subsequent fixation of the hemorrhoidal cushion. Cryosurgery may be associated with a higher rate of complication and less patient satisfaction [<a href="#rid74">74</a>].</p><p></p><p class="headingAnchor" id="H438686987"><span class="h2">Postprocedure care and follow-up</span><span class="headingEndMark"> — </span>Following office-based procedures, patients are instructed to avoid constipation by using stool softeners and consuming a diet high in fiber and water. If the patient experiences anal or rectal pain or discomfort, warm sitz baths and oral pain medication are advised. The postprocedure instructions are similar to those given following surgical hemorrhoidectomy. (See  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease", section on 'Postoperative care and follow-up'</a>.)</p><p>A rare but life-threatening complication with all office-based procedures is perineal sepsis, which is usually heralded by a triad of severe pain, urinary retention, and fever. Any patient with these symptoms should have follow-up immediately for further evaluation [<a href="#rid75">75</a>]. </p><p>The prevalence of rectal pathology among patients who present with symptomatic hemorrhoid disease is unknown. Following resolution of symptoms, it is reasonable to suggest a sigmoidoscopy if this has not been previously performed. A colonoscopy can be considered in patients with risk factors for colorectal cancer or in those older than 50 years of age, in whom it serves the added purpose of screening for colorectal cancer. (See <a class="local">'Refer for colonoscopy'</a> above.)</p><p class="headingAnchor" id="H1645925803"><span class="h1">SPECIAL PATIENT POPULATIONS</span></p><p class="headingAnchor" id="H1872261160"><span class="h2">Pregnant patients</span><span class="headingEndMark"> — </span>The prevalence of symptomatic hemorrhoidal disease is 25 to 35 percent during pregnancy, and it is particularly frequent in the last trimester of pregnancy and immediately postpartum [<a href="#rid76">76</a>]. Symptoms range from mild (eg, pruritus, discomfort) to severe (eg, intractable bleeding). Since symptoms generally improve after delivery, treatment during pregnancy is primarily conservative with emphasis on dietary and lifestyle modification, lying on the left side, and the use of mild laxatives and stool softeners to avoid constipation. Topical medications and oral phlebotonics should be used with caution in pregnant patients because data on long-term efficacy and safety are lacking. Surgical treatment (eg, hemorrhoidectomy) is rarely required and is only performed for strangulated or extensively thrombosed hemorrhoids or for intractable bleeding [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H317080189"><span class="h2">Immunocompromised patients</span><span class="headingEndMark"> — </span>Hemorrhoids in immunocompromised hosts should in general be managed conservatively because of the risk of sepsis and poor wound healing associated with any anorectal procedures [<a href="#rid77">77</a>]. If absolutely necessary, sclerotherapy is a safer option for bleeding hemorrhoids in this cohort of patients than either rubber band ligation or hemorrhoidectomy [<a href="#rid42">42,60</a>].</p><p class="headingAnchor" id="H3861373634"><span class="h2">Patients on anticoagulant or antiplatelet drugs</span><span class="headingEndMark"> — </span>Patients taking anticoagulants (eg, <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a>) or antiplatelet agents (eg, Plavix) often present with bleeding hemorrhoids. The bleeding episodes, however, are usually self-limited and do not require cessation or reversal of the medications. Most patients with low-grade hemorrhoids (I or II) respond to conservative management. For the rare patients who have persistent bleeding, sclerotherapy can be used. Rubber band ligation is contraindicated in patients who are on anticoagulant or antiplatelet medications because of a risk of catastrophic rectal bleeding after the eschar lifts off. If rubber band ligation or hemorrhoidectomy is required for high-grade or complicated hemorrhoids, these medications need to be stopped for five to seven days before the procedure [<a href="#rid2">2</a>]. </p><p class="headingAnchor" id="H2808264907"><span class="h2">Patients with portal hypertension</span><span class="headingEndMark"> — </span>Patients with portal hypertension, most commonly as a result of liver cirrhosis, often have rectal bleeding. The clinician needs to distinguish between rectal variceal bleeding and hemorrhoidal bleeding. The former is treated with suture ligation, transjugular intrahepatic portosystemic shunt, or medications to control portal hypertension. (See  <a class="medical medical_review" href="/d/html/1260.html" rel="external">"Methods to achieve hemostasis in patients with acute variceal hemorrhage", section on 'Management of ectopic varices'</a>.)</p><p>Hemorrhoidal bleeding in patients with portal hypertension is first treated conservatively. Patients who fail conservative management are usually treated with sclerotherapy. Rubber band ligation is contraindicated, again because of the risk for delayed bleeding. Patients who fail sclerotherapy require either suture ligation of the bleeding hemorrhoid or surgical hemorrhoidectomy [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H2842957788"><span class="h2">Patient with inflammatory bowel disease</span><span class="headingEndMark"> — </span>Historically, hemorrhoid surgery in patients with inflammatory bowel disease reportedly led to significant complications such as sepsis, stenosis, fistulas, fecal incontinence, nonhealing wounds, and even need for proctectomy. The complication rates were also substantially higher with Crohn disease than with ulcerative colitis.</p><p>Thus, most patients with inflammatory bowel disease who develop symptomatic hemorrhoids are managed conservatively with a high-fiber diet, oral hydration, warm sitz bath, and oral phlebotonics. Select patients with symptoms refractory to best medical therapy may be offered surgical treatment if their inflammatory bowel disease is under control, and such patients should be counselled regarding the high-risk nature of any intervention. </p><p>The optimal surgical treatment for this patient population is not known; most reports were based on small retrospective studies conducted many years ago [<a href="#rid78">78</a>]. However, surgeons often prefer conventional techniques such as hemorrhoidectomy, or minimally invasive techniques such as rubber band ligation or hemorrhoidal artery ligation, to hemorrhoidopexy due to the life-threatening complications associated with the latter [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H837733007"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/113186.html" rel="external">"Society guideline links: Hemorrhoids"</a>.)</p><p class="headingAnchor" id="H2184396001"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15404.html" rel="external">"Patient education: Hemorrhoids (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/2013.html" rel="external">"Patient education: Hemorrhoids (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3206506811"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial lifestyle modification for all symptomatic hemorrhoids</strong> – For all patients with symptomatic hemorrhoids, we recommend initial conservative treatment with dietary management consisting of adequate fluid and fiber intake (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). (See <a class="local">'Conservative treatment for all patients'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitive management for grade I, II, or III internal hemorrhoids</strong> – Most patients with low-grade (I or II) internal hemorrhoids respond favorably to conservative treatment and do not require any further treatment. Reasons to refer patients to a specialist include refractory or complicated hemorrhoids for possible intervention and rectal bleeding for possible colonoscopy. (See <a class="local">'Reasons to refer to a specialist'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients refractory to initial lifestyle modification</strong> – For patients with grade I, II, or III internal hemorrhoids refractory to conservative treatment, we recommend an office-based procedure, rather than surgical hemorrhoidectomy, as the initial intervention (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Compared with surgical treatment of hemorrhoids, most office-based procedures cause less pain and fewer complications. (See <a class="local">'Rubber band ligation'</a> above.) </p><p></p><p class="bulletIndent2">Commonly performed office-based procedures include rubber band ligation, sclerotherapy, and infrared coagulation of internal hemorrhoids. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For healthy patients with grade I, II, or III internal hemorrhoids, we recommend rubber band ligation rather another office-based procedure (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Compared with sclerotherapy or infrared coagulation, rubber band ligation is more effective and requires fewer treatment sessions. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Rubber band ligation is contraindicated in patients who are on anticoagulant or antiplatelet drugs, are immunocompromised, or have portal hypertension. In these patients, we suggest sclerotherapy rather than infrared coagulation (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Sclerotherapy is better studied in these patients. (See <a class="local">'Sclerotherapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitive management for grade IV internal hemorrhoids</strong> – Patients with grade IV internal hemorrhoids, those with combined internal and external hemorrhoids and significant prolapse, and those with another indication for anorectal surgery should be offered surgical hemorrhoidectomy if they fail conservative treatment. (See  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitive management for external hemorrhoids</strong> – Acutely thrombosed external hemorrhoids can be treated by office-based excision if the patient presents within the first three days of symptoms. The symptoms usually begin to subside after three days and typically dissipate in 7 to 10 days. Extensive or bleeding thrombosed external hemorrhoids may require surgical excision in the operating room. (See  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease", section on 'Thrombosed external hemorrhoids'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Jacobs D. Clinical practice. Hemorrhoids. N Engl J Med 2014; 371:944.</a></li><li><a class="nounderline abstract_t">Lohsiriwat V. Treatment of hemorrhoids: A coloproctologist's view. World J Gastroenterol 2015; 21:9245.</a></li><li><a class="nounderline abstract_t">Gazet JC, Redding W, Rickett JW. The prevalence of haemorrhoids. A preliminary survey. Proc R Soc Med 1970; 63 Suppl:78.</a></li><li><a class="nounderline abstract_t">Riss S, Weiser FA, Schwameis K, et al. The prevalence of hemorrhoids in adults. Int J Colorectal Dis 2012; 27:215.</a></li><li><a class="nounderline abstract_t">Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology 1990; 98:380.</a></li><li><a class="nounderline abstract_t">Yeung TM, D'Souza ND. Quality analysis of patient information on surgical treatment of haemorrhoids on the internet. Ann R Coll Surg Engl 2013; 95:341.</a></li><li><a class="nounderline abstract_t">Cusano F, Luciano S. Contact dermatitis from pramoxine. Contact Dermatitis 1993; 28:39.</a></li><li><a class="nounderline abstract_t">Kawada A, Noguchi H, Hiruma M, et al. Fixed drug eruption induced by lidocaine. Contact Dermatitis 1996; 35:375.</a></li><li><a class="nounderline abstract_t">Alonso-Coello P, Guyatt G, Heels-Ansdell D, et al. Laxatives for the treatment of hemorrhoids. Cochrane Database Syst Rev 2005; :CD004649.</a></li><li><a class="nounderline abstract_t">Moesgaard F, Nielsen ML, Hansen JB, Knudsen JT. High-fiber diet reduces bleeding and pain in patients with hemorrhoids: a double-blind trial of Vi-Siblin. Dis Colon Rectum 1982; 25:454.</a></li><li><a class="nounderline abstract_t">Rivadeneira DE, Steele SR, Ternent C, et al. Practice parameters for the management of hemorrhoids (revised 2010). Dis Colon Rectum 2011; 54:1059.</a></li><li><a class="nounderline abstract_t">Perez-Miranda M, Gomez-Cedenilla A, León-Colombo T, et al. Effect of fiber supplements on internal bleeding hemorrhoids. Hepatogastroenterology 1996; 43:1504.</a></li><li><a class="nounderline abstract_t">Lohsiriwat V. Hemorrhoids: from basic pathophysiology to clinical management. World J Gastroenterol 2012; 18:2009.</a></li><li><a class="nounderline abstract_t">Altomare DF, Rinaldi M, La Torre F, et al. Red hot chili pepper and hemorrhoids: the explosion of a myth: results of a prospective, randomized, placebo-controlled, crossover trial. Dis Colon Rectum 2006; 49:1018.</a></li><li><a class="nounderline abstract_t">Trompetto M, Clerico G, Cocorullo GF, et al. Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement. Tech Coloproctol 2015; 19:567.</a></li><li><a class="nounderline abstract_t">Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders. Drugs 1992; 44:1013.</a></li><li><a class="nounderline abstract_t">Meyer OC. Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease. Angiology 1994; 45:579.</a></li><li><a class="nounderline abstract_t">Godeberge P. Daflon 500 mg in the treatment of hemorrhoidal disease: a demonstrated efficacy in comparison with placebo. Angiology 1994; 45:574.</a></li><li><a class="nounderline abstract_t">Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology 1994; 45:566.</a></li><li><a class="nounderline abstract_t">Buckshee K, Takkar D, Aggarwal N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet 1997; 57:145.</a></li><li><a class="nounderline abstract_t">Misra MC, Parshad R. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids. Br J Surg 2000; 87:868.</a></li><li><a class="nounderline abstract_t">Ho YH, Foo CL, Seow-Choen F, Goh HS. Prospective randomized controlled trial of a micronized flavonidic fraction to reduce bleeding after haemorrhoidectomy. Br J Surg 1995; 82:1034.</a></li><li><a class="nounderline abstract_t">Orefice R, Litta F, Parello A, et al. A Prospective Study on the Efficacy of Two Different Phlebotonic Therapies as a Bridge to Surgery in Patients with Advanced Hemorrhoidal Disease. J Clin Med 2021; 10.</a></li><li><a class="nounderline abstract_t">Alonso-Coello P, Zhou Q, Martinez-Zapata MJ, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg 2006; 93:909.</a></li><li><a class="nounderline abstract_t">Perera N, Liolitsa D, Iype S, et al. Phlebotonics for haemorrhoids. Cochrane Database Syst Rev 2012; :CD004322.</a></li><li><a class="nounderline abstract_t">Gorfine SR. Treatment of benign anal disease with topical nitroglycerin. Dis Colon Rectum 1995; 38:453.</a></li><li><a class="nounderline abstract_t">Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 1997; 349:11.</a></li><li><a class="nounderline abstract_t">Tjandra JJ, Tan JJ, Lim JF, et al. Rectogesic (glyceryl trinitrate 0.2%) ointment relieves symptoms of haemorrhoids associated with high resting anal canal pressures. Colorectal Dis 2007; 9:457.</a></li><li><a class="nounderline abstract_t">van den Berg M, Stroeken HJ, Hoofwijk AG. [Favorable results of conservative treatment with isosorbide dinitrate in 25 patients with fourth-degree hemorrhoids: a pilot study]. Ned Tijdschr Geneeskd 2003; 147:971.</a></li><li><a class="nounderline abstract_t">Perrotti P, Antropoli C, Molino D, et al. Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine. Dis Colon Rectum 2001; 44:405.</a></li><li><a class="nounderline abstract_t">Patti R, Arcara M, Bonventre S, et al. Randomized clinical trial of botulinum toxin injection for pain relief in patients with thrombosed external haemorrhoids. Br J Surg 2008; 95:1339.</a></li><li><a class="nounderline abstract_t">Shafik A. Role of warm-water bath in anorectal conditions. The "thermosphincteric reflex". J Clin Gastroenterol 1993; 16:304.</a></li><li><a class="nounderline abstract_t">Dodi G, Bogoni F, Infantino A, et al. Hot or cold in anal pain? A study of the changes in internal anal sphincter pressure profiles. Dis Colon Rectum 1986; 29:248.</a></li><li><a class="nounderline abstract_t">Shanmugam V, Thaha MA, Rabindranath KS, et al. Rubber band ligation versus excisional haemorrhoidectomy for haemorrhoids. Cochrane Database Syst Rev 2005; :CD005034.</a></li><li><a class="nounderline abstract_t">Linares Santiago E, Gómez Parra M, Mendoza Olivares FJ, et al. Effectiveness of hemorrhoidal treatment by rubber band ligation and infrared photocoagulation. Rev Esp Enferm Dig 2001; 93:238.</a></li><li><a class="nounderline abstract_t">Poen AC, Felt-Bersma RJ, Cuesta MA, et al. A randomized controlled trial of rubber band ligation versus infra-red coagulation in the treatment of internal haemorrhoids. Eur J Gastroenterol Hepatol 2000; 12:535.</a></li><li><a class="nounderline abstract_t">Marques CF, Nahas SC, Nahas CS, et al. Early results of the treatment of internal hemorrhoid disease by infrared coagulation and elastic banding: a prospective randomized cross-over trial. Tech Coloproctol 2006; 10:312.</a></li><li><a class="nounderline abstract_t">Chand M, Nash GF, Dabbas N. The management of haemorrhoids. Br J Hosp Med (Lond) 2008; 69:35.</a></li><li><a class="nounderline abstract_t">MacRae HM, McLeod RS. Comparison of hemorrhoidal treatment modalities. A meta-analysis. Dis Colon Rectum 1995; 38:687.</a></li><li><a class="nounderline abstract_t">MacRae HM, McLeod RS. Comparison of hemorrhoidal treatments: a meta-analysis. Can J Surg 1997; 40:14.</a></li><li><a class="nounderline abstract_t">Nelson RS, Ewing BM, Ternent C, et al. Risk of late bleeding following hemorrhoidal banding in patients on antithrombotic prophylaxis. Am J Surg 2008; 196:994.</a></li><li><a class="nounderline abstract_t">Buchmann P, Seefeld U. Rubber band ligation for piles can be disastrous in HIV-positive patients. Int J Colorectal Dis 1989; 4:57.</a></li><li><a class="nounderline abstract_t">Khubchandani IT. A randomized comparison of single and multiple rubber band ligations. Dis Colon Rectum 1983; 26:705.</a></li><li><a class="nounderline abstract_t">Berkelhammer C, Moosvi SB. Retroflexed endoscopic band ligation of bleeding internal hemorrhoids. Gastrointest Endosc 2002; 55:532.</a></li><li><a class="nounderline abstract_t">Su MY, Chiu CT, Wu CS, et al. Endoscopic hemorrhoidal ligation of symptomatic internal hemorrhoids. Gastrointest Endosc 2003; 58:871.</a></li><li><a class="nounderline abstract_t">Fukuda A, Kajiyama T, Arakawa H, et al. Retroflexed endoscopic multiple band ligation of symptomatic internal hemorrhoids. Gastrointest Endosc 2004; 59:380.</a></li><li><a class="nounderline abstract_t">Wehrmann T, Riphaus A, Feinstein J, Stergiou N. Hemorrhoidal elastic band ligation with flexible videoendoscopes: a prospective, randomized comparison with the conventional technique that uses rigid proctoscopes. Gastrointest Endosc 2004; 60:191.</a></li><li><a class="nounderline abstract_t">Dickey W, Garrett D. Hemorrhoid banding using videoendoscopic anoscopy and a single-handed ligator: an effective, inexpensive alternative to endoscopic band ligation. Am J Gastroenterol 2000; 95:1714.</a></li><li><a class="nounderline abstract_t">Ramzisham AR, Sagap I, Nadeson S, et al. Prospective randomized clinical trial on suction elastic band ligator versus forceps ligator in the treatment of haemorrhoids. Asian J Surg 2005; 28:241.</a></li><li><a class="nounderline abstract_t">Iyer VS, Shrier I, Gordon PH. Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids. Dis Colon Rectum 2004; 47:1364.</a></li><li><a class="nounderline abstract_t">Cocorullo G, Tutino R, Falco N, et al. The non-surgical management for hemorrhoidal disease. A systematic review. G Chir 2017; 38:5.</a></li><li><a class="nounderline abstract_t">Bleday R, Pena JP, Rothenberger DA, et al. Symptomatic hemorrhoids: current incidence and complications of operative therapy. Dis Colon Rectum 1992; 35:477.</a></li><li><a class="nounderline abstract_t">Scarpa FJ, Hillis W, Sabetta JR. Pelvic cellulitis: a life-threatening complication of hemorrhoidal banding. Surgery 1988; 103:383.</a></li><li><a class="nounderline abstract_t">Wechter DG, Luna GK. An unusual complication of rubber band ligation of hemorrhoids. Dis Colon Rectum 1987; 30:137.</a></li><li><a class="nounderline abstract_t">Marshman D, Huber PJ Jr, Timmerman W, et al. Hemorrhoidal ligation. A review of efficacy. Dis Colon Rectum 1989; 32:369.</a></li><li><a class="nounderline abstract_t">Albuquerque A. Rubber band ligation of hemorrhoids: A guide for complications. World J Gastrointest Surg 2016; 8:614.</a></li><li><a class="nounderline abstract_t">Salgueiro P, Garrido M, Santos RG, et al. Polidocanol Foam Sclerotherapy Versus Rubber Band Ligation in Hemorrhoidal Disease Grades I/II/III: Randomized Trial. Dis Colon Rectum 2022; 65:e718.</a></li><li><a class="nounderline abstract_t">Khoury GA, Lake SP, Lewis MC, Lewis AA. A randomized trial to compare single with multiple phenol injection treatment for haemorrhoids. Br J Surg 1985; 72:741.</a></li><li><a class="nounderline abstract_t">Mann CV, Motson R, Clifton M. The immediate response to injection therapy for first-degree haemorrhoids. J R Soc Med 1988; 81:146.</a></li><li><a class="nounderline abstract_t">Scaglia M, Delaini GG, Destefano I, Hultén L. Injection treatment of hemorrhoids in patients with acquired immunodeficiency syndrome. Dis Colon Rectum 2001; 44:401.</a></li><li><a class="nounderline abstract_t">Kaman L, Aggarwal S, Kumar R, et al. Necrotizing fascitis after injection sclerotherapy for hemorrhoids: report of a case. Dis Colon Rectum 1999; 42:419.</a></li><li><a class="nounderline abstract_t">Barwell J, Watkins RM, Lloyd-Davies E, Wilkins DC. Life-threatening retroperitoneal sepsis after hemorrhoid injection sclerotherapy: report of a case. Dis Colon Rectum 1999; 42:421.</a></li><li><a class="nounderline abstract_t">Schulte T, Fändrich F, Kahlke V. Life-threatening rectal necrosis after injection sclerotherapy for haemorrhoids. Int J Colorectal Dis 2008; 23:725.</a></li><li><a class="nounderline abstract_t">Iwagaki H, Higuchi Y, Fuchimoto S, Orita K. The laser treatment of hemorrhoids: results of a study on 1816 patients. Jpn J Surg 1989; 19:658.</a></li><li><a class="nounderline abstract_t">O'Connor JJ. Infrared coagulation of hemorrhoids. Practical Gastroenterology 1986; 10:8.</a></li><li><a class="nounderline abstract_t">Ratto C, Campennì P, Papeo F, et al. Transanal hemorrhoidal dearterialization (THD) for hemorrhoidal disease: a single-center study on 1000 consecutive cases and a review of the literature. Tech Coloproctol 2017; 21:953.</a></li><li class="breakAll">National Institute for Health and Care Excellence (NICE). Interventional procedures guidance on electrotherapy for the treatment of haemorrhoids [IPG525]. 2015. Available at: https://www.nice.org.uk/guidance/ipg525 (Accessed on May 22, 2017).</li><li><a class="nounderline abstract_t">Kantsevoy SV, Bitner M. Nonsurgical treatment of actively bleeding internal hemorrhoids with a novel endoscopic device (with video). Gastrointest Endosc 2013; 78:649.</a></li><li><a class="nounderline abstract_t">Crawshaw BP, Russ AJ, Ermlich BO, et al. Prospective Case Series of a Novel Minimally Invasive Bipolar Coagulation System in the Treatment of Grade I and II Internal Hemorrhoids. Surg Innov 2016; 23:581.</a></li><li><a class="nounderline abstract_t">Hodgson WJ, Morgan J. Ambulatory hemorrhoidectomy with CO2 laser. Dis Colon Rectum 1995; 38:1265.</a></li><li><a class="nounderline abstract_t">Senagore A, Mazier WP, Luchtefeld MA, et al. Treatment of advanced hemorrhoidal disease: a prospective, randomized comparison of cold scalpel vs. contact Nd:YAG laser. Dis Colon Rectum 1993; 36:1042.</a></li><li><a class="nounderline abstract_t">Leff EI. Hemorrhoidectomy--laser vs. nonlaser: outpatient surgical experience. Dis Colon Rectum 1992; 35:743.</a></li><li><a class="nounderline abstract_t">Gill JR, Morrow JS, West AB. Fatal hemorrhage following laser hemorrhoidectomy. J Clin Gastroenterol 1994; 19:343.</a></li><li><a class="nounderline abstract_t">Buls JG, Goldberg SM. Modern management of hemorrhoids. Surg Clin North Am 1978; 58:469.</a></li><li><a class="nounderline abstract_t">McCloud JM, Jameson JS, Scott AN. Life-threatening sepsis following treatment for haemorrhoids: a systematic review. Colorectal Dis 2006; 8:748.</a></li><li><a class="nounderline abstract_t">Abramowitz L, Batallan A. [Epidemiology of anal lesions (fissure and thrombosed external hemorroid) during pregnancy and post-partum]. Gynecol Obstet Fertil 2003; 31:546.</a></li><li><a class="nounderline abstract_t">Morandi E, Merlini D, Salvaggio A, et al. Prospective study of healing time after hemorrhoidectomy: influence of HIV infection, acquired immunodeficiency syndrome, and anal wound infection. Dis Colon Rectum 1999; 42:1140.</a></li><li><a class="nounderline abstract_t">D'Ugo S, Franceschilli L, Cadeddu F, et al. Medical and surgical treatment of haemorrhoids and anal fissure in Crohn's disease: a critical appraisal. BMC Gastroenterol 2013; 13:47.</a></li></ol></div><div id="topicVersionRevision">Topic 1382 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25184866" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical practice. Hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26309351" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Treatment of hemorrhoids: A coloproctologist's view.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5525514" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The prevalence of haemorrhoids. A preliminary survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21932016" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The prevalence of hemorrhoids in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2295392" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The prevalence of hemorrhoids and chronic constipation. An epidemiologic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23838496" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Quality analysis of patient information on surgical treatment of haemorrhoids on the internet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8428445" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Contact dermatitis from pramoxine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9118644" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Fixed drug eruption induced by lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16235372" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Laxatives for the treatment of hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6284457" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : High-fiber diet reduces bleeding and pain in patients with hemorrhoids: a double-blind trial of Vi-Siblin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21825884" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Practice parameters for the management of hemorrhoids (revised 2010).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8975955" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Effect of fiber supplements on internal bleeding hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22563187" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Hemorrhoids: from basic pathophysiology to clinical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16708161" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Red hot chili pepper and hemorrhoids: the explosion of a myth: results of a prospective, randomized, placebo-controlled, crossover trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26403234" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1282862" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8203791" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8203790" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Daflon 500 mg in the treatment of hemorrhoidal disease: a demonstrated efficacy in comparison with placebo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8203789" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9184951" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Micronized flavonoid therapy in internal hemorrhoids of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10931020" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7648143" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prospective randomized controlled trial of a micronized flavonidic fraction to reduce bleeding after haemorrhoidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33917023" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A Prospective Study on the Efficacy of Two Different Phlebotonic Therapies as a Bridge to Surgery in Patients with Advanced Hemorrhoidal Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16736537" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Meta-analysis of flavonoids for the treatment of haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22895941" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Phlebotonics for haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7736873" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Treatment of benign anal disease with topical nitroglycerin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8988115" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17504344" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Rectogesic (glyceryl trinitrate 0.2%) ointment relieves symptoms of haemorrhoids associated with high resting anal canal pressures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12784532" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : [Favorable results of conservative treatment with isosorbide dinitrate in 25 patients with fourth-degree hemorrhoids: a pilot study].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11289288" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18844269" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Randomized clinical trial of botulinum toxin injection for pain relief in patients with thrombosed external haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8331263" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Role of warm-water bath in anorectal conditions. The "thermosphincteric reflex".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3948615" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Hot or cold in anal pain? A study of the changes in internal anal sphincter pressure profiles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16034963" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Rubber band ligation versus excisional haemorrhoidectomy for haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11488120" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Effectiveness of hemorrhoidal treatment by rubber band ligation and infrared photocoagulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10833097" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A randomized controlled trial of rubber band ligation versus infra-red coagulation in the treatment of internal haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17115317" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Early results of the treatment of internal hemorrhoid disease by infrared coagulation and elastic banding: a prospective randomized cross-over trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18293730" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The management of haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7607026" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Comparison of hemorrhoidal treatment modalities. A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9030078" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Comparison of hemorrhoidal treatments: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19095121" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Risk of late bleeding following hemorrhoidal banding in patients on antithrombotic prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2708884" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Rubber band ligation for piles can be disastrous in HIV-positive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6354644" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A randomized comparison of single and multiple rubber band ligations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11923767" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Retroflexed endoscopic band ligation of bleeding internal hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14652555" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Endoscopic hemorrhoidal ligation of symptomatic internal hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14997135" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Retroflexed endoscopic multiple band ligation of symptomatic internal hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15278043" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Hemorrhoidal elastic band ligation with flexible videoendoscopes: a prospective, randomized comparison with the conventional technique that uses rigid proctoscopes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10925973" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Hemorrhoid banding using videoendoscopic anoscopy and a single-handed ligator: an effective, inexpensive alternative to endoscopic band ligation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16234072" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Prospective randomized clinical trial on suction elastic band ligator versus forceps ligator in the treatment of haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15484351" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28460197" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The non-surgical management for hemorrhoidal disease. A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1568400" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Symptomatic hemorrhoids: current incidence and complications of operative therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3278407" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Pelvic cellulitis: a life-threatening complication of hemorrhoidal banding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3803121" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : An unusual complication of rubber band ligation of hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2714125" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Hemorrhoidal ligation. A review of efficacy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27721924" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Rubber band ligation of hemorrhoids: A guide for complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34840294" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Polidocanol Foam Sclerotherapy Versus Rubber Band Ligation in Hemorrhoidal Disease Grades I/II/III: Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3899248" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : A randomized trial to compare single with multiple phenol injection treatment for haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3357157" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The immediate response to injection therapy for first-degree haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11289287" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Injection treatment of hemorrhoids in patients with acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10223766" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Necrotizing fascitis after injection sclerotherapy for hemorrhoids: report of a case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10223767" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Life-threatening retroperitoneal sepsis after hemorrhoid injection sclerotherapy: report of a case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18043926" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Life-threatening rectal necrosis after injection sclerotherapy for haemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2607689" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The laser treatment of hemorrhoids: results of a study on 1816 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Infrared coagulation of hemorrhoids</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29170839" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Transanal hemorrhoidal dearterialization (THD) for hemorrhoidal disease: a single-center study on 1000 consecutive cases and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29170839" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Transanal hemorrhoidal dearterialization (THD) for hemorrhoidal disease: a single-center study on 1000 consecutive cases and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23891414" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Nonsurgical treatment of actively bleeding internal hemorrhoids with a novel endoscopic device (with video).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27448595" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Prospective Case Series of a Novel Minimally Invasive Bipolar Coagulation System in the Treatment of Grade I and II Internal Hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7497837" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Ambulatory hemorrhoidectomy with CO2 laser.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8223057" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Treatment of advanced hemorrhoidal disease: a prospective, randomized comparison of cold scalpel vs. contact Nd:YAG laser.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1643997" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Hemorrhoidectomy--laser vs. nonlaser: outpatient surgical experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7876522" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Fatal hemorrhage following laser hemorrhoidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/675462" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Modern management of hemorrhoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17032319" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Life-threatening sepsis following treatment for haemorrhoids: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12865195" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : [Epidemiology of anal lesions (fissure and thrombosed external hemorroid) during pregnancy and post-partum].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10496553" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Prospective study of healing time after hemorrhoidectomy: influence of HIV infection, acquired immunodeficiency syndrome, and anal wound infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23496835" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Medical and surgical treatment of haemorrhoids and anal fissure in Crohn's disease: a critical appraisal.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
